Michigan State University’s Dr. Norbert Kaminski Begins Pre-Clinical Study of GB Sciences’ Neuroprotective Cannabis …

 “GB Sciences is honored to be working with Dr. Kaminski on this project. He pioneered studies of the effects of cannabis on the immune system,” explains Dr. Andrea Small-Howard, Chief Science Officer of GB Sciences. “More recently, Dr, Kaminski’s work has centered around the immune modulating effects of cannabis consumption on HIV/AIDS patients. In 2017, he demonstrated a relationship between cannabis use and improved brain health in HIV/AIDS patients who used cannabis versus those who did not. Dr. Kaminski has further theorized that cannabis use by HIV/AIDS patients may reduce their risk of HIV-Associated Neurocognitive Disorder (HAND) by reducing levels of inflammatory white blood cells in their brains. This same neuroinflammation may be a major contributing factor in a number of related neurological disorders such as Parkinson’s disease and Alzheimer’s disease.”

GB Sciences holds a formidable Intellectual Properties portfolio and has engaged the cooperation of top research Universities and CRO’s

... read more at: https://www.prnewswire.com/news-releases/michigan-state-universitys-dr-norbert-kaminski-begins-pre-clinical-study-of-gb-sciences-neuroprotective-cannabis-compounds-for-parkinsons-disease-300692139.html